Rohan Shah Email & Phone Number

New York, Ny, Us

New York, Ny, Us

Emerging long-only public equities fund

New York, New York, Us

Research & Investments

Boston, Massachusetts, Us

In-licensing, Carve-outs

Chicago, Il, Us

- Involved in company building and direct investing into disruptive life sciences companies across indications, technologies, and modalities- Performing due diligence of promising academic science and direct investment opportunities primarily in oncology, immunology, and neuroscience- Providing operational assistance to Vilya Therapeutics, AIRNA Therapeutics, and a stealth company

Stamford, Ct, Us

Operating across discovery strategy, clinical development, diagnostics, and business development in oncology

- Alimtas is dedicated to increasing undergraduate exposure to the biopharmaceutical industry and life science entrepreneurship- Through a partnership with the Princeton Office of Technology Licensing, the organization helps the university spin out promising, high-impact life science technologies through rigorous due diligence and business development- Established a diverse team of 14 students and established biweekly mentorship from Merck & Co.- Raised $40,000 from Regeneron, Eli Lilly, Alnylam, Gilead, Merck & Co., Foundation Venture Capital Group, Princeton Entrepreneurial Council, Keller Center, Princeton Entrepreneurship Club, and Princeton University Department of Molecular Biology-Led team trips to Chicago and San Francisco to present to ARCH Venture Partners, Genentech, Vir Bio, 5AM Ventures, Mammoth Biosciences, and The Gladstone Institutes

Princeton, Nj, Us

Senior Thesis: Interrogating RNA Modifications Through Proximity Labeling and Platinum Molecular ProbesJunior Independent Work: Uncovering the Molecular Mechanisms of Action of Platinum TherapeuticsAdvisor: Assistant Professor Ralph E. KleinerTechniques: immunofluorescence, click-chemistry, mammalian cell culture, drug treatment, liquid chromatography mass spectrometry

Boston, Ma, Us

Under the mentorship of Alan Crane and Amir Nashat, I helped due diligence and create new ventures around promising, high-impact science as part of the Healthcare Team.

South San Francisco, California, Us

Developed in vitro assays to validate a next generation immuno-neurology target to activate microglia (resident immune cells in the central nervous system) to counter Amyloid and Tau pathologies responsible for Alzheimer's DiseaseWorked directly with the Chief Business Officer (Sabah Oney, Ph.D.) to diligence gene therapy in neurodegenerative disease ($30 - $40 million deal value)Presented directly to executive board and scientific leadershipLaboratory Techniques: mouse work, brain dissection, FACS, Western Blotting, Cytokine Bead Array, Metabolism assays

Cambridge, Ma, Us

Summer intern in the discovery group where I designed functional assays to validate next-generation immunoncology targets and test lead antibody candidates. Worked on "Wave Three" targets on TregsLaboratory Techniques: Fluorescence Activated Cell Sorting (BD Fortessa and Celesta with DIVA Software), Cytokine Bead Array analysis, Cell Culture, Blood Processing, Immune Cell Isolation, BrdU ELISA, Intracellular Cytokine Staining, Whole Blood Staining, Cyno & Rhesus Gene CloningSoftware: Flojo FACS Software, GraphPad Prism

New Brunswick, Nj, Us

Founded the Waksman Student Scholars Club at Robbinsville High School during my sophomore year. Waksman focuses on using real world applications to teach bioinformatics, molecular biology, genetic sequencing, and microbiology to high school students-Selected to participate in the three-week summer intensive program at the Waksman Institute of Rutgers University-Researched proteins in Landoltia punctate, better known as Duckweed, capable of being used in bioremediation and biofuels-With the support of the Board of Education, I transformed the the club into a curriculum class to promote biology research education

New York, Ny, Us

Rockefeller University Summer Science Research Program. In the laboratory of Dr. Günter Blobel, I structurally characterize the 3' UTR of RNA. Went from target validation to a digital RNA structure.Project Title: Structural Characterization of mRNA 3' Untranslated RegionThesis: Since mRNA 3' Untranslated Regions are evolutionarily conserved, they musthave a role in post-transcriptional regulation

New York, Ny, Us

Memorial Sloan- Kettering Human Oncology and Pathogenesis Summer Student Program. Under the mentorship of Dr. Charles L. Sawyers, researched prostate cancer drug resistance. Designed and executed a knock-down of a resistance pathway to the Enzalutamide, the current therapy for prostate cancer.Project Title: The Role of BRD4 in an Enzalutamide Resistant Prostate Cancer Cell LineThesis: By targeting BET Bromodomains that cause epigenetic modifications to the prostate cancer genome, it is possible to reduce the levels of the Glucocorticoid Receptor resistance pathway. Recapitulated the effect of JQ1, an experimental drug targeting BET Family Bromodomains, by using a short hairpin RNA screen

Master Of Business Administration - Mba

Master Of Science - Ms, Biotechnology

Bachelor’S Degree, Molecular Biology

High School